- Home
- CYCN vs NYC Comparison
CYCN vs NYC Comparison
Compare CYCN & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CYCN | NYC |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6M | 19.9M |
| IPO Year | 2019 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CYCN | NYC |
|---|---|---|
| Price | $3.36 | $6.45 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 90.6K | 25.8K |
| Earning Date | 05-08-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 8.26 | ★ 85.28 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,074,000.00 | N/A |
| Revenue This Year | N/A | $56.73 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.70 | N/A |
| 52 Week Low | $1.03 | $5.82 |
| 52 Week High | $8.48 | $13.97 |
Technical Indicators
Market Signals| Indicator | CYCN | NYC |
|---|---|---|
| Relative Strength Index (RSI) | 41.06 | 37.30 |
| Support Level | $3.04 | $5.97 |
| Resistance Level | $3.42 | $8.89 |
| Average True Range (ATR) | 0.49 | 0.39 |
| MACD | -0.03 | 0.05 |
| Stochastic Oscillator | 23.67 | 39.72 |
Price Performance
Historical ComparisonAbout CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others.
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.